Trademark applications and grants for Astex Therapeutics L T D. Astex Therapeutics L T D has 4 trademark applications. The latest application filed is for "ASTEX THERAPEUTICS"
Patent Application | Date |
---|---|
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY 20220204503 - 17/643083 CHESSARI; Gianni ;   et al. | 2022-06-30 |
PYRAZOLYL QUINOXALINE KINASE INHIBITORS 20220135544 - 17/451601 SAXTY; Gordon ;   et al. | 2022-05-05 |
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY 20220106287 - 17/228151 CHESSARI; Gianni ;   et al. | 2022-04-07 |
ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS 20220089590 - 17/350183 Cooper; Anthony William James ;   et al. | 2022-03-24 |
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY 20210276984 - 17/164045 CHESSARI; Gianni ;   et al. | 2021-09-09 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "ASTEX THERAPEUTICS" 78684737 |
ASTEX THERAPEUTICS 2005-08-03 |
![]() "ASTEX TECHNOLOGY" 4081552 76086645 |
ASTEX TECHNOLOGY 2000-07-11 |
![]() "HTX" 2661442 76086646 |
HTX 2000-07-11 |
![]() "AUTOSOLVE" 2611559 76086644 |
AUTOSOLVE 2000-07-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.